Clinical trials are critical to advancing cancer treatment, but keeping your research program afloat during a pandemic is a challenge. Raju K. Vaddepally, MD, Hematology/Oncology, Yuma Regional Medical Center Cancer Center, discusses strategies for sustaining a robust clinical trials program in uncertain times, how to increase the relevance of research to vulnerable and underserved patients, and answers to your questions.
View On-Demand Replay

This webcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., and Pfizer, Inc.